This immunogenicity taken together with frequent expression showed above strongly suggests that MAGE-C1/CT7 and MAGE-C2/CT10 are potential candidates for cancer immunotherapy in a large group of melanoma patients. The gene discussed is MAGEC1; the disease is cancer.